Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Claire Boisset is active.

Publication


Featured researches published by Claire Boisset.


Current Microbiology | 2003

A Novel, Highly Viscous Polysaccharide Excreted by an Alteromonas Isolated from a Deep-Sea Hydrothermal Vent Shrimp

Gérard Raguénès; Marie Anne Cambon-Bonavita; Jean François Lohier; Claire Boisset; Jean Guezennec

A deep-sea, mesophilic, aerobic, and heterotrophic microorganism, able to produce an extracellular polysaccharide, was isolated from a shrimp collected near an active hydrothermal vent of the Mid-Atlantic Ridge. On the basis of phenotypic and phylogenetic analyses and DNA/DNA relatedness, this strain could be assigned to the species Alteromonas macleodii as a variant of the fijiensis subspecies. It was selected for its ability to exhibit a swarming mucoid phenotype on specific media. The bacterium secreted, under laboratory conditions, an extremely viscous exopolysaccharide consisting of glucose, galactose as neutral sugars, and glucuronic, galacturonic acids as uronic acids, along with pyruvate and acetate as main substituents.


Carbohydrate Polymers | 2012

Structural data on a bacterial exopolysaccharide produced by a deep-sea Alteromonas macleodii strain

T. Le Costaouëc; S. Cérantola; David Ropartz; Jacqueline Ratiskol; Corinne Sinquin; Sylvia Colliec-Jouault; Claire Boisset

Some marine bacteria collected around deep-sea hydrothermal vents are able to produce, in laboratory conditions, complex and innovative exopolysaccharides. In a previous study, the mesophilic strain Alteromonas macleodii subsp. fijiensis biovar deepsane was collected on the East Pacific Rise at 2600 m depth. It was isolated from a polychaete annelid Alvinella pompejana and is able to synthesise and excrete the exopolysaccharide deepsane. Biological activities have been screened and some protective properties have been established. Deepsane is commercially available in cosmetics under the name of Abyssine(®) for soothing and reducing irritation of sensitive skin against chemical, mechanical and UVB aggression. This study presents structural data for this original and complex bacterial exopolysaccharide and highlights some structural similarities with other known EPS produced by marine Alteromonas strains.


Marine Drugs | 2008

Floridoside Extracted from the Red Alga Mastocarpus stellatus Is a Potent Activator of the Classical Complement Pathway

Anthony Courtois; Christelle Simon-Colin; Claire Boisset; Christian Berthou; Eric Deslandes; Jean Guezennec; Anne Bordron

Many biological properties of algae have been found to have useful applications in human health, particularly in the fields of oncology and immunology. Floridoside, extracted from the red alga Mastocarpus stellatus, has a structure similar to the xenoantigen Gal alpha 1–3 Gal. This xenoantigen has been described to induce a high immune response in human xenografts and is mediated by natural anti-gal antibodies that activate the classical complement pathway. Based on this property, we analyzed the potential activities of floridoside on the immune system. We demonstrated that floridoside activates a complement cascade via the classical complement pathway, through the recruitment and activation of natural IgM. This algal molecule could represent an important step in the development of a potent new anticomplementary agent for use in therapeutic complement depletion.


PLOS ONE | 2014

Exopolysaccharides isolated from hydrothermal vent bacteria can modulate the complement system.

Anthony Courtois; Christian Berthou; Jean Guezennec; Claire Boisset; Anne Bordron

The complement system is involved in the defence against bacterial infection, or in the elimination of tumour cells. However, disturbances in this system contributes to the pathogenesis of various inflammatory diseases. The efficiency of therapeutic anti-tumour antibodies is enhanced when the complement system is stimulated. In contrast, cancer cells are able to inhibit the complement system and thus proliferate. Some marine molecules are currently being developed as new drugs for use in humans. Among them, known exopolyssacharides (EPSs) generally originate from fungi, but few studies have been performed on bacterial EPSs and even fewer on EPSs extracted from deep-sea hydrothermal vent microbes. For use in humans, these high molecular weight EPSs must be depolymerised. Furthermore, the over-sulphation of EPSs can modify their biological activity. The aim of this study was to investigate the immunodulation of the complement system by either native or over-sulphated low molecular weight EPSs isolated from vent bacteria in order to find pro or anti-activators of complement.


Journal of Applied Microbiology | 2012

Real‐time PCR optimization to identify environmental Vibrio spp. strains

Amadou Tall; Anna Teillon; Claire Boisset; R. Delesmont; A. Touron-bodilis; Dominique Hervio-Heath

To identify Vibrio vulnificus, Vibrio cholerae and Vibrio alginolyticus using standardized DNA extraction method and real‐time PCR assays, among a large number of bacterial strains isolated from marine environment.


Journal of Microbiological Methods | 2012

Medium-throughput profiling method for screening polysaccharide-degrading enzymes in complex bacterial extracts

Maude Fer; Aurélie Préchoux; Andréa Leroy; Jean-François Sassi; Marc Lahaye; Claire Boisset; Pi Nyvall-Collén; William Helbert

Polysaccharides are the most abundant and the most diverse renewable materials found on earth. Due to the stereochemical variability of carbohydrates, polysaccharide-degrading enzymes - i.e. glycoside hydrolases and polysaccharide lyases - are essential tools for resolving the structure of these complex macromolecules. The exponential increase of genomic and metagenomic data contrasts sharply with the low number of proteins that have ascribed functions. To help fill this gap, we designed and implemented a medium-throughput profiling method to screen for polysaccharide-degrading enzymes in crude bacterial extracts. Our strategy was based on a series of filtrations, which are absolutely necessary to eliminate any reducing sugars not directly generated by enzyme degradation. In contrast with other protocols already available in the literature, our method can be applied to any panel of polysaccharides having known and unknown structures because no chemical modifications are required. We applied this approach to screen for enzymes that occur in Pseudoalteromonas carrageenovora grown in two culture conditions.


Applied Microbiology and Biotechnology | 2015

Exopolysaccharide biosynthesis and biodegradation by a marine hydrothermal Alteromonas sp. strain

Florian Lelchat; Joëlle Cozien; Tinaïg Le Costaouec; Christophe Brandilly; Sophie Schmitt; Anne-Claire Baudoux; Sylvia Colliec-Jouault; Claire Boisset

Alteromonas macleodii subsp. fijiensis biovar deepsane is a deep-sea ecotype exopolysaccharide-producing bacteria isolated from the polychaete annelid Alvinella pompejana. The high molecular weight biopolymer HYD657 produced by this strain, is the first marine exopolysaccharide (EPS) to be commercialized for cosmetic use. Depolymerization methods are necessary to elucidate the complete structure of this EPS and to generate potentially bioactive oligosaccharides. Enzymatic methods are useful for elucidating polysaccharide structure because they specifically cleave glycosidic bonds and do not require harsh chemical conditions. The HYD657 EPS is structurally complex and no commercially available enzymes are able to effectively degrade it. Here, we present the first results on the endogenous enzymatic depolymerization of a marine EPS of biotechnological interest by the producing strain. Enzymatic activity was detected in the bacterial lysate and was able to decrease the apparent molecular size of the EPS, releasing mainly oligosaccharides. The reduced form of the native polysaccharide showed a slightly modified osidic composition, particularly in terms of molar ratio. Several exoglycosidase activities were measured in the bacterial lysate using paranitrophenyl-osides.


Synlett | 2007

Total Synthesis of Floridoside

Bertrand Thollas; Claire Boisset


Archive | 2005

Use of Low-Molecular-Weight Highly Sulfated Polysaccharide Derivatives for Modulating Angiogenesis

Sabine Matou; Sylvia Colliec-Jouault; Dominique Helley; Jacqueline Ratiskol; Corinne Sinquin; Claire Boisset; Jean Guezennec; Anne-Marie Fischer


Electronic Journal of Biotechnology | 2012

Complement dependent cytotoxicity activity of therapeutic antibody fragments is acquired by immunogenic glycan coupling

Anthony Courtois; Stéphanie Gac-Breton; Christian Berthou; Jean Guezennec; Anne Bordron; Claire Boisset

Collaboration


Dive into the Claire Boisset's collaboration.

Researchain Logo
Decentralizing Knowledge